FDA Adverse Event Injury Summary report: N

ACESSA GUIDANCE HANDPIECE

MDR report key: 5828247 · Received July 27, 2016

Report

Report Number
3006443171-2016-00003
Event Type
Injury
Date Received
July 27, 2016
Date of Event
June 21, 2016
Report Date
July 11, 2016
Manufacturer
HALT MEDICAL, INC.
Product Code
HFG
PMA / PMN Number
K121858
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION (LOT# 160101). (B)(6) REVIEWED THE ACESSA SYSTEM HAZARD ANALYSIS (B)(4). REVIEW DETERMINED THAT THIS TYPE OF RISK MAY OCCUR (HAZARD ANALYSIS I.D. (B)(4)) WHICH WOULD RESULT IN PATIENT BURN WHEN RF IS APPLIED AND THE DEVICE IS NOT POSITIONED CORRECTLY, IN THIS CASE THE ACCIDENTAL ABLATION OF BLADDER TISSUE. THIS "THERMAL INJURY" ISSUE IS THE 2ND OCCURRENCE IN APPROXIMATELY (B)(4) CASES. EACH CASE AVERAGES 4-6 FIBROID TREATMENTS, THEREFORE, THERE ARE APPROXIMATELY (B)(4) ABLATIONS PERFORMED WITH ONLY (B)(4) KNOWN CASES OF "THERMAL INJURY". THE RATE OF FREQUENCY IS CONSIDERED (B)(4). IN ADDITION, WE ALSO DO NOT KNOW IF THE MYOMECTOMY PROCEDURE MAY HAVE CONTRIBUTED TO THIS "THERMAL INJURY" ISSUE. NOT RETURNED TO MANUFACTURER.

Description of Event or Problem · 1

ON (B)(6) 2016 DR. (B)(6) TREATED A PATIENT FOR UTERINE FIBROIDS WITH THE ACESSA PROCEDURE AT (B)(6) CENTER, (B)(6). THE PATIENT COMPLAINED OF BLADDER SYMPTOMS AND A BLADDER INJURY WAS DIAGNOSED BY AN UROLOGIST VIA A CYSTOSCOPY ON THE INNER WALL OF THE BLADDER. DR. (B)(6) CONTACTED THE SALES DIRECTOR OF (B)(6) MEDICAL ON (B)(6) 2016 AND NOTIFIED HIM THAT HIS PATIENT EXPERIENCE A THERMAL BLADDER INJURY. THE PATIENT WAS TREATED FOR UTI AND REPORTED TO BE DOING WELL. IT WAS ALSO NOTED AFTER THE ACESSA PROCEDURE, A DECISION WAS MADE TO PERFORM AN ABDOMINAL MYOMECTOMY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
477948 ACESSA GUIDANCE HANDPIECE GUIDANCE HANDPIECE HFG HALT MEDICAL, INC. 5300 160101

Patients

Seq Age Sex Outcome Treatment
1